The Pfizer Frontiers in Human Disease Symposium aims to address rapidly emerging areas of biomedical science and technology that will influence future development of novel therapeutics. This year’s topic,“The Role of Cilia in Biology and Medicine,” will be presented by widely recognized thought leaders who perform highly impactful research in the topic area.
9:15 a.m. – 9:30 a.m. ET | Log in |
9:30 a.m. – 9:45 a.m. ET | Welcome – Morris J. Birnbaum, MD, PhD Opening Remarks – Peter Jackson, PhD |
Session 1
9:45 a.m. – 10:30 a.m. ET | Lukas Sommer, PhD University of Zurich Professor, Medical Faculty and Faculty of Science “ The Role of Cilia in Tumorigenesis” | Abstract |
10:30 a.m. – 11:15 a.m. | Jing Hughes, MD, PhD Washington University School of Medicine in St. Louis Associate Professor of Medicine, Division of Endocrinology, Metabolism & Lipid Research “Primary cilia in pancreatic islet function” | Abstract |
11:15 a.m. – 11:30 a.m. ET | Break |
11:30 a.m. – 12:15 a.m. ET | Gaia Pigino, PhD Human Technopole Associate Head of Structural Biology Research Center “Structural cell biology of cilia and intraflagellar transport” | Abstract |
12:15 a.m. – 1:00 p.m. ET | Breakout Session: Group Networking/Office Hours with Session 1 speakers |
1:00 p.m. – 2:00 p.m. ET | Lunch |
Session 2
2:00 p.m. – 2:45 p.m. ET | Rajat Rohatgi, MD, PhD Stanford University School of Medicine Associate Professor of Biochemistry and of Medicine (Oncology) “ Cholesterol accessibility at the ciliary membrane regulates Hedgehog signaling” | Abstract |
2:45 p.m. – 3:30 p.m. ET | Ken-Ichi Takemaru, PhD Stony Brook University Professor, Department of Pharmacological Sciences “Chibby Family Members and Their Regulators in Ciliogenesis and Ciliopathies” | Abstract |
3:30 p.m. – 3:35 p.m. ET | Closing Remarks – Morris J. Birnbaum, M.D., Ph.D. Pfizer, SVP-Chief Scientific Officer, Internal Medicine Research Unit |
3:35 p.m. - 4:20 p.m. ET | Breakout Session: Group Networking/Office Hours with Session 2 speakers |
4:20 p.m. ET | End of Day 1 |
9:15 a.m. – 9:30 a.m. | Log in |
9:30 a.m. – 9:45 a.m. | Welcome – Morris J. Birnbaum, MD, PhD Opening Remarks – Mikael Dolsten, MD, PhD |
Session 3
9:45 a.m. – 10:30 a.m | Pleasantine Mill, PhD University of Edinburgh Group Leader, MRC Human Genetics Unit, Institute of Genetics and Cancer “Cilia in Development and Disease: Dynamics, Diversity and Reversing Disease Phenotypes” | Abstract |
10:30 a.m. – 11:15 a.m. | Bradley Yoder, PhD University of Alabama Professor / Chairperson, Cell, Developmental, and Integrative Biology “Cilia, injury, and cystic kidney diseases” | Abstract |
11:15 a.m. – 11:30 a.m. | Break |
11:30 a.m. – 12:15 a.m. | Cecilia Lo, PhD University of Pittsburgh Distinguished Professor and F. Sargent Cheever Chair, Department of Developmental Biology “Cilia in the complex genetics of congenital heart disease” | Abstract |
12:15 a.m. – 1:00 a.m. | Breakout Session: Group Networking/Office Hours with Session 3 speakers |
1:00 p.m. – 2:00 p.m. | Lunch |
Session 4
2:00pm-2:45pm ET | David Clapham, MD, PhD Howard Hughes Medical Institute Janelia Group Leader “A serotonergic axon-cilium synapse drives nuclear signaling in the brain” | Abstract |
2:45pm-3:30pm ET | Peter Jackson, PhD Stanford University School of Medicine Professor of Microbiology and Immunology (Baxter Labs) and of Pathology “Ciliary Control of Metabolic Signaling” | Abstract |
3:30pm-3:35pm ET | Closing Remarks - Morris J. Birnbaum, MD, PhD Pfizer, SVP-Chief Scientific Officer, Internal Medicine Research Unit |
3:35pm-4:20pm ET | Breakout Session: Group Networking/Office Hours with Session 4 speakers |
4:20 ET | End of Symposium |